PTEN at the crossroad of metabolic diseases and cancer in the liver
The tumor suppressor PTEN is a phosphoinositide phosphatase regulating the PI3K/Akt signaling pathways and mutated or deleted in a variety of human cancers. Recent evidence indicates that dysregulated PTEN expression and activity in the liver critically affect hepatic insulin sensitivity and trigger...
Main Authors: | Manlio Vinciguerra, Michelangelo Foti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-07-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119318484 |
Similar Items
-
Non-alcoholic fatty liver disease: features of metabolic changes at different stages of the disease
by: Yu.M. Stepanov, et al.
Published: (2018-02-01) -
Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
by: Serena Scapaticci, et al.
Published: (2021-04-01) -
Insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
by: Esther Ubiña-Aznar, et al. -
Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
by: Teresa Auguet, et al.
Published: (2014-12-01) -
Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
by: Arash Dooghaie Moghadam, et al.
Published: (2020-06-01)